141 related articles for article (PubMed ID: 38367283)
21. Impact of the 21-gene expression assay on treatment decisions and clinical outcomes in breast cancer with one to three positive lymph nodes.
Li GQ; Xie SJ; Wu SG; He ZY
Front Endocrinol (Lausanne); 2023; 14():1103949. PubMed ID: 36875478
[TBL] [Abstract][Full Text] [Related]
22. The prognostic differences and the effect of postmastectomy radiotherapy between post-chemotherapy ypT1-2ypN1 and de novo pT1-2N1 breast cancer.
Yang T; Zhong X; Wang J; Xiang Z; Zeng Y; Yu S; Dai Z; Xu N; Luo T; Liu L
Cancer Med; 2023 Apr; 12(7):8112-8121. PubMed ID: 36734308
[TBL] [Abstract][Full Text] [Related]
23. 21-Gene Recurrence Score Assay Could Not Predict Benefit of Post-mastectomy Radiotherapy in T1-2 N1mic ER-Positive HER2-Negative Breast Cancer.
Zhang WW; Tong Q; Sun JY; Hua X; Long ZQ; Deng JP; Dong Y; Li FY; He ZY; Wu SG; Lin HX
Front Oncol; 2019; 9():270. PubMed ID: 31041190
[No Abstract] [Full Text] [Related]
24. Practical Model to Optimize the Strategy of Adjuvant Postmastectomy Radiotherapy in T1-2N1 Breast Cancer With Modern Systemic Therapy.
Xu FF; Cao L; Xu C; Cai G; Wang SB; Qi WX; Chen JY
Front Oncol; 2022; 12():789198. PubMed ID: 35280719
[TBL] [Abstract][Full Text] [Related]
25. Impact of the 21-gene recurrence score assay on chemotherapy decision making and outcomes for breast cancer patients with four or more positive lymph nodes.
Zhang QH; Zhang WW; Wang J; Lian CL; Sun JY; He ZY; Wu SG
Ann Transl Med; 2019 Sep; 7(18):446. PubMed ID: 31700882
[TBL] [Abstract][Full Text] [Related]
26. Intraoperative radiotherapy versus whole-breast external beam radiotherapy, and other factors associated with the prognosis of early breast cancer treated with breast-conserving surgery and radiotherapy: a retrospective study from SEER database.
Sun MS; Liu HJ; Liu YH; Xu L; Ye JM
Transl Cancer Res; 2020 Nov; 9(11):7125-7139. PubMed ID: 35117317
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of Adjuvant Treatments for T1 N0 M0 Triple-Negative Breast Cancer.
Zhai Z; Zheng Y; Yao J; Liu Y; Ruan J; Deng Y; Zhou L; Zhao P; Yang S; Hu J; We B; Wu Y; Zhang D; Kang H; Dai Z
JAMA Netw Open; 2020 Nov; 3(11):e2021881. PubMed ID: 33211105
[TBL] [Abstract][Full Text] [Related]
28. Effect of breast-conserving surgery plus radiotherapy versus mastectomy on breast cancer-specific survival for early-stage contralateral breast cancer.
Qian C; Liang Y; Yang M; Bao SN; Bai JL; Yin YM; Yu H
Gland Surg; 2021 Oct; 10(10):2978-2996. PubMed ID: 34804885
[TBL] [Abstract][Full Text] [Related]
29. Comparison of long-term results between radiotherapy after breast-conserving surgery and postmastectomy radiotherapy in stage T1-2N1M0 breast cancer.
Lan XW; Wen G; He Z; Huang JH; Zou XB; Lin X; Tan YT; Huang XB
Cancer Manag Res; 2019; 11():6477-6487. PubMed ID: 31372049
[TBL] [Abstract][Full Text] [Related]
30. Noninferior Outcome After Breast-Conserving Treatment Compared to Mastectomy in Breast Cancer Patients With Four or More Positive Lymph Nodes.
Wang J; Deng JP; Sun JY; Dong Y; Zhang WW; He ZY; Wu SG
Front Oncol; 2019; 9():143. PubMed ID: 30931256
[No Abstract] [Full Text] [Related]
31. Survival outcome of adjuvant chemotherapy and high 21-gene recurrence score in early-stage breast cancer.
Ma SJ; Oladeru OT; Farrugia M; Mikucki M; Iovoli A; Shekher R; Sood A; Singh AK
Breast J; 2021 Jan; 27(1):27-34. PubMed ID: 33274486
[TBL] [Abstract][Full Text] [Related]
32. Molecular subtypes of breast cancer predicting clinical benefits of radiotherapy after breast-conserving surgery: a propensity-score-matched cohort study.
Hung SK; Yang HJ; Lee MS; Liu DW; Chen LC; Chew CH; Lin CH; Lee CH; Li SC; Hong CL; Yu CC; Yu BH; Hsu FC; Chiou WY; Lin HY
Breast Cancer Res; 2023 Dec; 25(1):149. PubMed ID: 38066611
[TBL] [Abstract][Full Text] [Related]
33. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
34. The survival benefit of postmastectomy radiotherapy for breast cancer patients with T1-2N1 disease according to molecular subtype.
Wei J; Jiang Y; Shao Z
Breast; 2020 Jun; 51():40-49. PubMed ID: 32200207
[TBL] [Abstract][Full Text] [Related]
35. Postoperative radiotherapy improves survival of patients with ypN2 non-small cell lung cancer after neoadjuvant chemotherapy followed by surgery - A propensity score matching study of the Surveillance, Epidemiology, and End Results database.
Bao Y; Yang X; Men Y; Kang J; Sun X; Zhao M; Sun S; Yuan M; Ma Z; Hui Z
Thorac Cancer; 2022 Feb; 13(3):404-411. PubMed ID: 34907665
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant chemotherapy in patients with invasive lobular carcinoma and use of the 21-gene recurrence score: A National Cancer Database analysis.
Weiser R; Polychronopoulou E; Hatch SS; Haque W; Ghani HA; He J; Kuo YF; Gradishar WJ; Klimberg VS
Cancer; 2022 May; 128(9):1738-1747. PubMed ID: 35137951
[TBL] [Abstract][Full Text] [Related]
37. Is repeat breast conservation possible for small ipsilateral breast cancer recurrence?
Li Y; Li WW; Yuan L; Xu B
Cancer; 2022 Nov; 128(22):3919-3928. PubMed ID: 36128621
[TBL] [Abstract][Full Text] [Related]
38. Impact of the 21-gene recurrence score on outcome in patients with invasive lobular carcinoma of the breast.
Kizy S; Huang JL; Marmor S; Tuttle TM; Hui JYC
Breast Cancer Res Treat; 2017 Oct; 165(3):757-763. PubMed ID: 28647915
[TBL] [Abstract][Full Text] [Related]
39. Development and validation of nomograms for predicting survival outcomes in patients with T1-2N1 breast cancer to identify those who could not benefit from postmastectomy radiotherapy.
Pu H; Luo Y; Zhang L; Li X; Li F; Chen J; Qian S; Tang Y; Zhao X; Hou L; Gao Y
Front Oncol; 2023; 13():1112687. PubMed ID: 37056328
[TBL] [Abstract][Full Text] [Related]
40. 21-Gene Recurrence Score Assay Predicts Benefit of Post-Mastectomy Radiotherapy in T1-2 N1 Breast Cancer.
Goodman CR; Seagle BL; Kocherginsky M; Donnelly ED; Shahabi S; Strauss JB
Clin Cancer Res; 2018 Aug; 24(16):3878-3887. PubMed ID: 29685878
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]